GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neurizon Therapeutics NUZ.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.06

-6.25%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Neurizon Therapeutics

Our reporting

We have not reported on Neurizon Therapeutics yet.

Past results

Reported against what analysts expected

30 Aug 202429 Feb 202431 Aug 202327 Feb 202330 Jun 202231 Dec 2021
Earnings per share-0.02-0.00-0.02-0.00-0.00-0.00
Revenue—A$857,347A$908,813A$1.9mA$910,995A$1.7m

Key events

  1. 30 Oct 201520-to-1 reverse split
  2. 5 Oct 2001Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.